Search

everythinglearnresearchcommunity

for

Search:↓

Human hair-derived particles can effectively carry and release the cancer drug Paclitaxel in a pH-sensitive manner, potentially targeting cancer cells while sparing healthy ones.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

New cancer treatments aim to reduce side effects and improve effectiveness.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Etoposide makes radiation therapy more effective against tumors without major side effects.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

Promising cancer treatments were found, but the manufacturer closed.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.